# Major Depressive Disorder:  Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/major-depressive-disorder-developing-drugs-for-treatment/8f70f512-6f81-4d11-86f6-e2abe0d6dcc0

> FDA guidance document: Major Depressive Disorder:  Developing Drugs for Treatment. Issue date: June 21, 2018. Get complete insights and analysis.

---

## Details

- Title: Major Depressive Disorder:  Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-06-21
- Comment Close Date: 2018-09-20
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1919">FDA-2018-D-1919</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonalcoholic-steatohepatitis-with-compensated-cirrhosis-developing-drugs-for-treatment-guidance-for-industry/71c114f5-4930-4cda-87ef-12936678931f)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)